Lv22
126 积分 2025-04-11 加入
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
2小时前
待确认
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
1天前
已完结
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension
3天前
已完结
Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy
3天前
已完结
Design and Synthesis of Inhibitors of the E3 Ligase SMAD Specific E3 Ubiquitin Protein Ligase 1 as a Treatment for Lung Remodeling in Pulmonary Arterial Hypertension
4天前
已完结
ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension
5天前
已完结
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
8天前
已完结
Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension
8天前
已完结
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study
9天前
已完结
Epidemiology and treatment of pulmonary arterial hypertension
11天前
已完结
皖公网安备34019202002308
